NEW DELHI: The Center said Monday that the battle against the pandemic was still far from over and briefed Parliament on its balanced unlocking approach to reviving the economy while seeking sustained community support to break the chain of transmission of Covid-19 . Making a suo-moto statement on the Covid-19 …
Read More »Covaxin Update: Bharat Biotech’s Covid Vaccine Generated a “Robust Immune Response” in Animals | India News
NEW DELHI: Hyderabad-based leading vaccine Bharat Biotech has announced that its Covid-19 vaccine candidate, Covaxin, during its tests on animal rhesus macaques, has developed a “robust immune response” to the highly infectious coronavirus, “preventing infections and diseases in primates after large amounts of exposure to the live SARS-CoV-2 virus ”. …
Read More »Covid Roundup: Prime Minister’s Warning Message, UK Vaccine Trials Resume and More | India News
NEW DELHI: Warning people not to let their guard down until an effective coronavirus drug is developed, Prime Minister Narendra Modi on Saturday devised a catchphrase in Hindi to emphasize his point. He said: ‘Jab tak dawai nahi, tab tak dhilai nahi’ (There is no neglect until a medicine is …
Read More »DCGI Orders Serum Institute of India to Suspend Recruitment for Oxford Covid-19 Vaccine Trials | India News
NEW DELHI: The Controller General of Medicines of India (DCGI) has directed the Serum Institute of India to suspend until new hires are ordered in the phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate in the context of the pharmaceutical giant AstraZeneca stopping trials in other …
Read More »Serum Stops Oxford Vaccine Trials Following DCGI Notice | India News
Representative image NEW DELHI/ MUMBAI: Serum Institute of India stopped the Covishield trials, Oxford University-AstraZenecaCandidate for the Covid-19 vaccine, after a notice issued by the central drug regulator. “We are reviewing the situation and stopping the trials in India until AstraZeneca restarts them. We are following the instructions of the …
Read More »‘Significant Move’ in Russia’s Request for Phase 3 Trial, Sputnik V Manufacturing in India | India News
NEW DELHI: India is considering Russia’s request to conduct a phase 3 clinical trial and the manufacture of its Covid-19 Sputnik V vaccine by Indian companies, officials said Tuesday, noting there has been “significant movement” on both fronts. and specific results are expected. soon. Dr VK Paul, Member (Health) Niti …
Read More »